TriSalus Life Sciences, Inc. (TLSI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for TriSalus Life Sciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.74x | -4.00x | -3.77x | -6.29x | -10.70x | -10.10x |
| P/B Ratio | -7.81x | -5.13x | -8.26x | -24.10x | 9.99x | -6.41x |
| P/S Ratio | 5.86x | 4.51x | 12.08x | 23.95x | 36.75x | 0.00x |
| Profitability | ||||||
| Gross Margin | 84.6% | 86.1% | 85.9% | 81.8% | 85.8% | 0.0% |
| Operating Margin | -59.7% | -122.9% | -294.3% | -293.9% | -286.1% | 0.0% |
| Net Margin | -86.9% | -112.9% | -320.7% | -380.6% | -343.4% | 0.0% |
| EBITDA Margin | -59.7% | -122.9% | -316.9% | -377.2% | -280.5% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.80x | 2.02x | 1.42x | 0.53x | 5.51x | 0.11x |
| Quick Ratio | 2.54x | 1.63x | 1.25x | 0.49x | 5.31x | 0.10x |
| Leverage | ||||||
| Debt/Equity | -1.02x | -0.91x | -0.06x | -0.16x | 0.00x | -0.84x |
YoY = year-over-year change. Source: FMP..